Nitrome Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Nitrome Biosciences's estimated annual revenue is currently $5.4M per year.
- Nitrome Biosciences's estimated revenue per employee is $155,000
Employee Data
- Nitrome Biosciences has 35 Employees.
- Nitrome Biosciences grew their employee count by 6% last year.
Nitrome Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO/CSO | Reveal Email/Phone |
Nitrome Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Nitrome Biosciences?
Nitrome Biosciences has discovered and identified a new class of enzymes. As a platform company developing drugs against a newly identified class of enzymes, we will have found and characterized this class of enzymes and will have paved a novel inroad into the proprietary development of disease-modifying therapies. We are initially targeting Parkinson's disease and developing cures for multiple aging-dependent diseases, including other neurodegenerative diseases, Type II diabetes, heart disease and cancer.
keywords:N/A
N/A
Total Funding
35
Number of Employees
$5.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nitrome Biosciences News
2022-03-30 - Nitrase Therapeutics Receives New Grant from The Michael J ...
Nitrase Therapeutics (under the former name Nitrome Biosciences) has been widely recognized and has won multiple awards including the...
Other Companies in Brisbane
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.9M | 35 | 0% | N/A |
#2 | $2.8M | 35 | 6% | N/A |
#3 | N/A | 35 | 46% | N/A |
#4 | $6.9M | 35 | -30% | N/A |
#5 | N/A | 35 | 52% | N/A |